• The volume of returned red blood cells in a large blood salvage program: where does it all go?
  Transfusion 2011; 51: 2126-2132.


• The impact of national transfusion indicators on appropriate blood usage in critically ill patients
  Transfusion 2011; 51: 1957-1965.


• Blood product use in trauma resuscitation: plasma deficit versus plasma ratio as predictors of mortality in trauma
  Transfusion 2011; 51: 1925-1932.

The best reviews from the journals.

• Management of major trauma haemorrhage: treatment priorities and controversies
  British Journal of Haematology 2011; 155: 537-548 
• Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.
  British Journal of Haematology 2011; 153 (5): 568-581 
• Risk-based decision-making for blood safety: preliminary report of a consensus conference
  Vox Sanguinis 2011; 101: 277-281 

• Complications in sickle cell disease
  Dr. Claire Sharpe, King's College London School of Medicine
  
• Treating deep vein thrombosis and pulmonary embolism in the elderly - current perspectives
  Alain Leizorovicz¹ MD and Mark Crowther² MD, MSc, FRCP
  ¹Faculté de Médecine Laennec, Service de Pharmacologie Clinique, Lyon, France
  ²Division of Hematology, McMaster University, Hamilton, Ontario, Canada
  
• Animal models for new and therapeutic approaches to sickle cell disease
  Lucia de Franceschi, Department of Medicine, University of Verona and AOUI; Verona; Italy
  

Slide atlas

Slide of the week: